Bumjoon Kim, MS
Experimental Research Scientist
Bumjoon Kim completed his BS in Chemical Engineering at Hanyang University and MS in Biomedical Engineering at Duke University. His previous research focused on biomaterials, drug delivery systems, and light-activated CRISPR-based cell therapies. In the Theodoris lab, he is applying experimental genomics and induced pluripotent disease modeling to map the gene regulatory networks driving cardiovascular disease and develop novel network-correcting therapies.